Elisa Giovannetti

Research interests

Publications

• Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy

  Journal of Hematology & Oncology · 2024 · 10.1186/s13045-024-01559-0

• Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9

  Nature Communications · 2021 · 10.1038/s41467-021-21550-4

• The role of alternative splicing in cancer: From oncogenesis to drug resistance

  Drug Resistance Updates · 2020 · 10.1016/j.drup.2020.100728

• Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer

  British Journal of Cancer · 2019 · 10.1038/s41416-019-0573-8

• Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets

  Cancer Cell · 2017 · 10.1016/j.ccell.2017.07.004

• Drug resistance in pancreatic cancer: Impact of altered energy metabolism

  Critical Reviews in Oncology/Hematology · 2017 · 10.1016/j.critrevonc.2017.03.026

• Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

  Cancer Chemotherapy and Pharmacology · 2016 · 10.1007/s00280-016-3003-0

• Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future

  The Oncologist · 2015 · https://doi.org/10.1634/theoncologist.2014-0044

• MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

  Oncotarget · 2015 · https://doi.org/10.18632/oncotarget.5495

• Analysis of Drug Interactions

  Methods in molecular biology · 2011 · 10.1007/978-1-61779-080-5_34

• Discovery of N -Hydroxyindole-Based Inhibitors of Human Lactate Dehydrogenase Isoform A (LDH-A) as Starvation Agents against Cancer Cells

  Journal of Medicinal Chemistry · 2011 · 10.1021/jm101007q

• Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

  PLoS ONE · 2010 · 10.1371/journal.pone.0010630

• MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

  Cancer Research · 2010 · https://doi.org/10.1158/0008-5472.can-09-4467

• Correlation of CDA, ERCC1, and XPD Polymorphisms with Response and Survival in Gemcitabine/Cisplatin–Treated Advanced Non–Small Cell Lung Cancer Patients

  Clinical Cancer Research · 2008 · 10.1158/1078-0432.ccr-07-1364

• Transcription Analysis of Human Equilibrative Nucleoside Transporter-1 Predicts Survival in Pancreas Cancer Patients Treated with Gemcitabine

  Cancer Research · 2006 · 10.1158/0008-5472.can-05-4203

Current projects

No projects listed.